Grant: Alliance Grants
Université de Montréal
$60,000.00
Exploring emerging chemical space for accelerated drug discovery
EF 2024-25
Résumé
In this project titled Exploring Emerging Chemical Space for Accelerated Drug Discovery, three organic
chemistry professors from UdeM (Cecioni, Lebel, Collins) are joining forces with Paraza Pharma, Inc. to
accelerate drug discovery through the development of novel technologies for chemical synthesis. We are
will investigate new ways to construct innovative 3D-rich chemical architectures. At the molecular level, the
shape and atom composition of molecules controls their interaction with biological targets, ultimately driving
potential therapeutic benefits. Traditionally, medicinal chemists assemble building blocks that are composed of
mostly flat molecular parts. Our objective is to discover new chemical reactions that enable easy preparation of
more complex 3D structures. Expanding our reach into such diverse chemical matter will develop unique
Canadian expertise in the pharmaceutical sector through accelerated discovery, reduced costs via sustainable
chemical methods, training of needed highly qualified personnel and perhaps ultimately, development of new
therapeutic agents.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
586349-2023
Name nom
Cecioni, Samy S
Department département
Chimie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
60000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3704
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Synthetic methodology
Research subject fr
Méthodologie en synthèse
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Exploring emerging chemical space for accelerated drug discovery
Keywords
catalysis; glycochemistry; heterocyclic chemistry; late-stage functionalization; medicinal chemistry; non-classical bioisosteres; organic chemistry; photochemistry; sustainable chemistry; synthetic methodology
Application summary
In this project titled Exploring Emerging Chemical Space for Accelerated Drug Discovery, three organic
chemistry professors from UdeM (Cecioni, Lebel, Collins) are joining forces with Paraza Pharma, Inc. to
accelerate drug discovery through the development of novel technologies for chemical synthesis. We are
will investigate new ways to construct innovative 3D-rich chemical architectures. At the molecular level, the
shape and atom composition of molecules controls their interaction with biological targets, ultimately driving
potential therapeutic benefits. Traditionally, medicinal chemists assemble building blocks that are composed of
mostly flat molecular parts. Our objective is to discover new chemical reactions that enable easy preparation of
more complex 3D structures. Expanding our reach into such diverse chemical matter will develop unique
Canadian expertise in the pharmaceutical sector through accelerated discovery, reduced costs via sustainable
chemical methods, training of needed highly qualified personnel and perhaps ultimately, development of new
therapeutic agents.